Laura M. Daniel

Array ( [id] => 10430101 [patent_doc_number] => 20150315113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'POLYTHIOLS AS CIS/TRANS ISOMERIZATION CATALYSTS FOR UNSATURATED COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/651510 [patent_app_country] => US [patent_app_date] => 2013-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10476 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10436959 [patent_doc_number] => 20150321971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'EFFICIENT PROCESS OF ASYMMETRIC HYDROGENATION OF UNSATURATED KETONES USING ADDITIVES' [patent_app_type] => utility [patent_app_number] => 14/651505 [patent_app_country] => US [patent_app_date] => 2013-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8598 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414190 [patent_doc_number] => 20150299200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'AN IMPROVED PROCESS FOR THE PREPARATION OF LINAGLIPTIN' [patent_app_type] => utility [patent_app_number] => 14/652230 [patent_app_country] => US [patent_app_date] => 2013-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3665 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10421228 [patent_doc_number] => 20150306239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'Carrier-Linked Prostanoid Prodrugs' [patent_app_type] => utility [patent_app_number] => 14/650175 [patent_app_country] => US [patent_app_date] => 2013-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26991 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9369774 [patent_doc_number] => 20140079647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'CEFDINIR AND CEFIXIME FORMULATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/089355 [patent_app_country] => US [patent_app_date] => 2013-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5615 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14089355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10422522 [patent_doc_number] => 20150307533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'SPIROCYCLIC SULFONES AS GAMMA SECRETASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/647769 [patent_app_country] => US [patent_app_date] => 2013-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9368 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10608092 [patent_doc_number] => 09328115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Process for preparing meropenem trihydrate' [patent_app_type] => utility [patent_app_number] => 14/655875 [patent_app_country] => US [patent_app_date] => 2013-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4199 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9450066 [patent_doc_number] => 20140121236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'Compositions and Methods for Treating Myotonic Dystrophy Type 1' [patent_app_type] => utility [patent_app_number] => 14/084468 [patent_app_country] => US [patent_app_date] => 2013-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9759 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12927748 [patent_doc_number] => 09828360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors [patent_app_type] => utility [patent_app_number] => 14/442522 [patent_app_country] => US [patent_app_date] => 2013-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32050 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 849 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11100862 [patent_doc_number] => 20160297832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'THIENO[3,2-C]PYRIDIN-4(5H)-ONES AS BET INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/442122 [patent_app_country] => US [patent_app_date] => 2013-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94639 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10437075 [patent_doc_number] => 20150322087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'CEPHALOSPORIN DERIVATIVES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/439373 [patent_app_country] => US [patent_app_date] => 2013-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13811 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307163 [patent_doc_number] => 20140045837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => '9-Substituted 8-Oxoadenine Compound' [patent_app_type] => utility [patent_app_number] => 14/058064 [patent_app_country] => US [patent_app_date] => 2013-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42933 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14058064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11331678 [patent_doc_number] => 09522915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Method for preparing an important intermediate of linagliptin' [patent_app_type] => utility [patent_app_number] => 14/436566 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11194 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10220371 [patent_doc_number] => 20150105364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'NMDA Receptor Modulators and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/050641 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10857 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14050641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10389727 [patent_doc_number] => 20150274735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'USE OF A TETRASUBSTITUTED PYRAZOLO[4, 3-D]PYRIMIDINE COMPOUND FOR TREATING DIABETIC NEPHROPATHY' [patent_app_type] => utility [patent_app_number] => 14/434236 [patent_app_country] => US [patent_app_date] => 2013-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5788 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10700508 [patent_doc_number] => 20160046655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'NOVEL PROCESS FOR PREPARING CEFTAROLINE FOSAMIL' [patent_app_type] => utility [patent_app_number] => 14/436493 [patent_app_country] => US [patent_app_date] => 2013-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5333 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430162 [patent_doc_number] => 20150315175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'PRODUCTION METHOD FOR CYCLOPENTANONE DERIVATIVE, INTERMEDIATE COMPOUND, AND PRODUCTION METHOD FOR INTERMEDIATE COMPOUND' [patent_app_type] => utility [patent_app_number] => 14/647483 [patent_app_country] => US [patent_app_date] => 2013-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6491 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10361925 [patent_doc_number] => 20150246931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'PROCESS FOR THE PREPARATION OF TAZOBACTAM' [patent_app_type] => utility [patent_app_number] => 14/426213 [patent_app_country] => US [patent_app_date] => 2013-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4226 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11428990 [patent_doc_number] => 09567298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Crystal forms of azetidinone compounds and preparing methods thereof' [patent_app_type] => utility [patent_app_number] => 14/426085 [patent_app_country] => US [patent_app_date] => 2013-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 8334 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340400 [patent_doc_number] => 20150225404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'PYRIDINE DERIVATIVE AND MEDICINE' [patent_app_type] => utility [patent_app_number] => 14/424469 [patent_app_country] => US [patent_app_date] => 2013-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59609 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424469 [rel_patent_id] =>[rel_patent_doc_number] =>)